Ixazomib for Desensitization

NCT03213158 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Kidney Diseases
End Stage Renal Disease

Interventions

DRUG: Ixazomib Oral Capsule

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]